BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2481673)

  • 1. Expression and developmental regulation of the k-FGF oncogene in human and murine embryonal carcinoma cells.
    Tiesman J; Rizzino A
    In Vitro Cell Dev Biol; 1989 Dec; 25(12):1193-8. PubMed ID: 2481673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the K-fgf proto-oncogene is controlled by 3' regulatory elements which are specific for embryonal carcinoma cells.
    Curatola AM; Basilico C
    Mol Cell Biol; 1990 Jun; 10(6):2475-84. PubMed ID: 2188089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of fibroblast growth factor receptors by embryonal carcinoma cells and early mouse embryos.
    Campbell WJ; Miller KA; Anderson TM; Shull JD; Rizzino A
    In Vitro Cell Dev Biol; 1992 Jan; 28A(1):61-6. PubMed ID: 1370443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional regulation of the murine k-fgf gene.
    Rizzino A; Rosfjord E
    Mol Reprod Dev; 1994 Sep; 39(1):106-11. PubMed ID: 7999355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the K-fgf protooncogene is repressed during differentiation of F9 cells.
    Velcich A; Delli-Bovi P; Mansukhani A; Ziff EB; Basilico C
    Oncogene Res; 1989; 5(1):31-7. PubMed ID: 2780052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. k-FGF protoncogene expression is associated with murine testicular teratogenesis, but is not involved during mouse testicular development.
    de Anta JM; Monzó M; Peris B; Ruano D
    Histol Histopathol; 1997 Jan; 12(1):33-41. PubMed ID: 9046041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential activity of the FGF-4 enhancer in F9 and P19 embryonal carcinoma cells.
    Boer B; Bernadt CT; Desler M; Wilder PJ; Kopp JL; Rizzino A
    J Cell Physiol; 2006 Jul; 208(1):97-108. PubMed ID: 16523502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of growth factors related to fibroblast growth factor and platelet-derived growth factor by human embryonal carcinoma cells.
    Tiesman J; Meyer A; Hines RN; Rizzino A
    In Vitro Cell Dev Biol; 1988 Dec; 24(12):1209-16. PubMed ID: 3209587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast growth factor-mediated growth regulation and receptor expression in embryonal carcinoma and embryonic stem cells and human germ cell tumours.
    Mummery CL; van Rooyen M; Bracke M; van den Eijnden-van Raaij J; van Zoelen EJ; Alitalo K
    Biochem Biophys Res Commun; 1993 Feb; 191(1):188-95. PubMed ID: 7680555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutive expression of fibroblast growth factor-4 does not alter the growth or the differentiation of embryonal carcinoma cells.
    Miller K; Rizzino A
    Cell Growth Differ; 1996 Feb; 7(2):203-11. PubMed ID: 8822204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional regulation of the murine k-FGF gene in embryonic cell lines.
    Ma YG; Rosfjord E; Huebert C; Wilder P; Tiesman J; Kelly D; Rizzino A
    Dev Biol; 1992 Nov; 154(1):45-54. PubMed ID: 1426633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific retinoid receptors cooperate to signal growth suppression and maturation of human embryonal carcinoma cells.
    Spinella MJ; Kitareewan S; Mellado B; Sekula D; Khoo KS; Dmitrovsky E
    Oncogene; 1998 Jul; 16(26):3471-80. PubMed ID: 9692555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of fibroblast growth factor by F9 teratocarcinoma cells as a function of differentiation.
    Braunhut SJ; Gudas LJ; Kurokawa T; Sasse J; D'Amore PA
    J Cell Biol; 1989 Jun; 108(6):2467-76. PubMed ID: 2544608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NF-Y binds to the CCAAT box motif of the FGF-4 gene and promotes FGF-4 expression in embryonal carcinoma cells.
    Lamb KA; Johnson LR; Rizzino A
    Mol Reprod Dev; 1997 Nov; 48(3):301-9. PubMed ID: 9322240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constitutive gene expression predisposes morphogen-mediated cell fate responses of NT2/D1 and 27X-1 human embryonal carcinoma cells.
    Chadalavada RS; Korkola JE; Houldsworth J; Olshen AB; Bosl GJ; Studer L; Chaganti RS
    Stem Cells; 2007 Mar; 25(3):771-8. PubMed ID: 17138961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation and expression of transforming growth factor type-beta during early mammalian development.
    Kelly D; Campbell WJ; Tiesman J; Rizzino A
    Cytotechnology; 1990 Nov; 4(3):227-42. PubMed ID: 1366990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FGF4 dissociates anti-tumorigenic from differentiation signals of retinoic acid in human embryonal carcinomas.
    Maerz WJ; Baselga J; Reuter VE; Mellado B; Myers ML; Bosl GJ; Spinella MJ; Dmitrovsky E
    Oncogene; 1998 Aug; 17(6):761-7. PubMed ID: 9715278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the transcription factor Sox-2 in the expression of the FGF-4 gene in embryonal carcinoma cells.
    Johnson LR; Lamb KA; Gao Q; Nowling TK; Rizzino A
    Mol Reprod Dev; 1998 Aug; 50(4):377-86. PubMed ID: 9669521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroblast growth factor inhibits proliferation of a highly tumorigenic insulin-independent teratoma-derived cell line.
    Zhou J; Serrero G
    Growth Factors; 1993; 9(2):123-31. PubMed ID: 8217215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of fibroblast growth factor and FGF-receptor family genes in human myeloma cells, including lines possessing t(4;14)(q16.3;q32. 3) and FGFR3 translocation.
    Otsuki T; Yamada O; Yata K; Sakaguchi H; Kurebayashi J; Nakazawa N; Taniwaki M; Yawata Y; Ueki A
    Int J Oncol; 1999 Dec; 15(6):1205-12. PubMed ID: 10568829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.